Innovative business models to advance access to next generation mAbs
Wellcome Trust
International AIDS Vaccine Initiative
The goal of this proposal is to convene a workshop that will help define novel business models bridging across innovators, biosimilar companies, product development partners, and other global stakeholders that place access at their core from the outset, for the next generation of mAbs. The aim of the proposed convening will be to harness expert insights to define approaches that promote timely, equitable, and sustainable access to mAbs in LMICs, with a focus on infectious disease mAbs in the pipeline. The workshop is co-convened by Unitaid, IAVI, and Medicines Patent Pool, with support from Wellcome. By convening key experts and stakeholders in a global dialogue around novel business models for mAbs access, we hope to advance several key outcomes: • Raising awareness and generating momentum around the need for alternative business models • Fostering collective dialogue and garnering expert advice in thinking through key aspects of business model innovation to inform partnership strategies and approaches • Cultivating strategic partnerships for novel business models for mAbs access
No Research Activity assigned